A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT05664737 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

BIOLOGICAL: Luspatercept
DRUG: Placebo

Sponsor

Bristol-Myers Squibb